Table 5 Sonographic and clinical factors for coronary artery complications in children with Kawasaki disease
From: Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children
Variables | Normal coronary artery (n = 43) | Abnormal coronary artery (n = 24) | Pvalue | OR (95% CI) |
|---|---|---|---|---|
Sonographic factors | ||||
Abnormal GB | 10 (23.3%) | 14 (58.3%) | 0.007* | 4.620 (1.574 ~ 13.558) |
GB distension | 6 (14.0%) | 13 (54.2%) | 0.001* | 7.288 (2.243 ~ 23.681) |
GB wall thickness | 4 (9.3%) | 2 (8.3%) | 1.000 | 0.886 (0.150 ~ 5.235) |
GB sludge | 2 (4.7%) | 0 (0%) | 0.533 | 0.953 (0.893 ~ 1.019) |
Abnormal liver | 9 (21.4%) | 4 (16.7%) | 0.755 | 0.733 (0.199 ~ 2.697) |
Clinical factors | ||||
Typical Kawasaki disease | 22(51.2%) | 17(70.8%) | 0.132 | 0.186 (0.011 ~ 3.081) |
Fever ≥ 5 days | 39(90.7%) | 22(91.7%) | 1.000 | 0.241 (0.012 ~ 4.910) |
Dysmorphous skin rash | 36(83.7%) | 22(91.7%) | 0.472 | 1.711 (0.241 ~ 12.164) |
Oral mucosal change | 32(74.4%) | 20(83.3%) | 0.545 | 0.832 (0.145 ~ 4.768) |
Conjunctivitis | 37(86.0%) | 19(79.2%) | 0.505 | 0.144 (0.012 ~ 1.725) |
Cervical lymphadenopathy | 27(62.8%) | 20(83.3%) | 0.099 | 2.504 (0.558 ~ 11.225) |
Peripheral extremity change | 20(46.5%) | 14(58.3%) | 0.447 | 1.498 (0.444 ~ 5.055) |
IVIG resistance | 10 (24.4%) | 7 (30.4%) | 0.769 | 1.356 (0.434 ~ 4.236) |
Hyperbilirubinemia | 19 (44.2%) | 19 (79.2%) | 0.009* | 4.800 (1.513 ~ 15.227) |